<--- Back to Details
First PageDocument Content
Pharmacology / Food and Drug Administration / Biotechnology / Genomics / Center for Biologics Evaluation and Research / Biomarker / Biologic / Personalized medicine / National Institutes of Health / Medicine / Biology / Health
Pharmacology
Food and Drug Administration
Biotechnology
Genomics
Center for Biologics Evaluation and Research
Biomarker
Biologic
Personalized medicine
National Institutes of Health
Medicine
Biology
Health

Revolutions and Resolutions– Some Perspectives for 2008

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 399,66 KB

Share Document on Facebook

Similar Documents

Large ElectronPositron Collider

Biotechnology, BS "DBEFNJD.BQ  5IF"DBEFNJD.BQTFSWFTBTBTVHHFTUFEDPVSTFTFRVFODFPOMZ4UVEFOUTBSFOPUMJNJUFEUPUIJTQMBOJUJTNFBOUUPCFVTFEBT

DocID: 1xTqy - View Document

PDF Document

DocID: 1wroO - View Document

Building A Better Mousetrap: Patenting Biotechnology In The European Community

DocID: 1vr7C - View Document

BIOTECH & PHARMA IN FRANCE KEY FACTS & FIGURES ¾¾ The French biotechnology sector ranks number 3 in Europe with more than 400 companies behind the UK and Germany ¾¾ First producer of medicines in Europe with 220 prod

DocID: 1vq6b - View Document

Biotechnology Consultation Agency Response Letter BNF

DocID: 1vpUZ - View Document